Abstract-Variants in the gene encoding the ␥-subunit of the epithelial sodium channel (SCNN1G) are associated with both Mendelian and quantitative effects on blood pressure. Here, in 4 cohorts of 1611 white European families composed of a total of 8199 individuals, we undertook staged testing of candidate single-nucleotide polymorphisms for SCNN1G (supplemented with imputation based on data from the 1000 Genomes Project) followed by a meta-analysis in all of the families of the strongest candidate. We also examined relationships between the genotypes and relevant intermediate renal phenotypes, as well as expression of SCNN1G in human kidneys. We found that an intronic single-nucleotide polymorphism of SCNN1G (rs13331086) was significantly associated with age-, sex-, and body mass index-adjusted blood pressure in each of the 4 populations (PϽ0.05). In an inverse variance-weighted meta-analysis of this single-nucleotide polymorphism in all 4 of the populations, each additional minor allele copy was associated with a 1-mm Hg increase in systolic blood pressure and 0.52-mm Hg increase in diastolic blood pressure (SEϭ0.33, Pϭ0.002 for systolic blood pressure; SEϭ0.21, Pϭ0.011 for diastolic blood pressure). The same allele was also associated with higher 12-hour overnight urinary potassium excretion (Pϭ0.04), consistent with increased epithelial sodium channel activity. Renal samples from hypertensive subjects showed a nonsignificant (Pϭ0.07) 1.7-fold higher expression of SCNN1G compared with normotensive controls. These data provide genetic and phenotypic evidence in support of a role for a common genetic variant of SCNN1G in blood pressure determination. A number of independent studies including our own have consistently shown an association between the SCNN1G locus and BP variation in the general population. [1] [2] [3] [4] [5] [6] [7] More recently, in the Victorian Family Heart Study (VFHS), we used a selective genotyping approach by comparing genotypes in unrelated individuals in the highest and lowest systolic BP (SBP) deciles to identify associated single-nucleotide polymorphisms (SNPs) in a gene-centered analysis of SCNN1G. 8 This approach identified 6 SNPs with association to BP. In the present study we extend our observations by undertaking much larger and more comprehensive analyses in the VFHS and in 3 other independent populations. Our strategy was to initially test the 6 SCNN1G candidate SNPs in all of the available participants of the VFHS and also in the Utah High Risk Pedigree Study (UPS). 9 From these we selected the 2 most strongly associated SNPs for testing in 2 additional independent family studies, the Silesian Hypertension Study (SHS) 10 and the Genetic Regulation of Arterial Pressure of Humans in the Community (GRAPHIC) 7 cohorts. We then combined data from all of the family studies in a 
T he epithelial sodium channel (ENaC) plays a vital role in blood pressure (BP) regulation. Mutations in the gene encoding the ␥-subunit of ENaC, SCNN1G, have been identified as causes of Mendelian forms of hypertension and hypotension. A number of independent studies including our own have consistently shown an association between the SCNN1G locus and BP variation in the general population. [1] [2] [3] [4] [5] [6] [7] More recently, in the Victorian Family Heart Study (VFHS), we used a selective genotyping approach by comparing genotypes in unrelated individuals in the highest and lowest systolic BP (SBP) deciles to identify associated single-nucleotide polymorphisms (SNPs) in a gene-centered analysis of SCNN1G. 8 This approach identified 6 SNPs with association to BP. In the present study we extend our observations by undertaking much larger and more comprehensive analyses in the VFHS and in 3 other independent populations. Our strategy was to initially test the 6 SCNN1G candidate SNPs in all of the available participants of the VFHS and also in the Utah High Risk Pedigree Study (UPS). 9 From these we selected the 2 most strongly associated SNPs for testing in 2 additional independent family studies, the Silesian Hypertension Study (SHS) 10 and the Genetic Regulation of Arterial Pressure of Humans in the Community (GRAPHIC) 7 cohorts. We then combined data from all of the family studies in a meta-analysis of the highest ranked SNP and examined its association to several available biochemical intermediate phenotypes. Finally, using the human kidney samples from the Silesian Renal Tissue Bank we have investigated the correlation among hypertension, the genotype of SCNN1G, and its renal expression at the transcript level. 11 
Methods

Study Populations
A total of 8199 individuals of white European ancestry from 1611 families recruited into 4 cohorts, the VFHS, 12 the UPS, 9 the SHS, 10 and the GRAPHIC, 7 were included in the association analysis. Details of the recruitment and phenotypic measures for each of the cohorts have been published previously and are summarized in Table  S1 (available in the online Data Supplement at http://hyper.aha journals.org). In brief, the VFHS and GRAPHIC families were recruited from the general population and the SHS and the UPS were recruited through probands with high cardiovascular risk. BP/ hypertension was a primary phenotype of interest in all 4 of the studies. SBPs and diastolic BPs (DBPs) were measured using standard sphygmomanometry in the VFHS and SHS and using automated devices in the UPS (Infrasonde SR-2 Automatic Blood Pressure Recorder, Sphygmetrics Inc, Woodlands, CA) and GRAPHIC (Omron HEM-705CP digital BP monitor) cohorts. In all of the cohorts, subjects had 3 BP measurements taken. Representative measures used in this study were those used originally by the specific cohorts: for the SHS this was the average of the 3 measurements, and in the VFHS, UPS, and GRAPHIC this was the average of the last 2 measurements.
The UPS cohort is a prospective study with data available at baseline and 25-year follow-up time points. Only the recent 25-year follow-up time point was used in the present study. In 648 of the UPS participants, urinary concentrations of sodium, potassium, and aldosterone were obtained from a 12-hour overnight urine sample at the same 25-year follow-up time point. Plasma sodium and potassium from fasting blood samples were obtained for 1292 of the UPS participants. 13, 14 The Silesian Renal Tissue Bank is a collection of human kidneys obtained from adult Polish patients (all of white European ancestry) with noninvasive renal cancer who underwent elective unilateral nephrectomy. 11 BP measurements were conducted (in triplicate) in each subject according to the protocol used in the SHS. 10 Hypertension was defined as SBP and/or DBP Ն140/90 mm Hg on Ն3 separate occasions and/or treatment with antihypertensive medication.
Genotyping and Quality Control
Genotyping was first performed in all of the subjects from the VFHS and UPS cohorts on 6 SNPs identified previously in the VFHS based on evidence of suggestive association with SBP (PϽ0.1) in our earlier selective genotyping case-control study (rs13331086, rs11074553, rs4299163, rs5740, rs4281710, and rs4470152). 8 Genotyping was performed using the LightScanner High Resolution Melting platform (Idaho Technology), which resolves genotype based on melting temperature of the DNA strands. Genotyping of the 2 SNPs with strongest evidence of association with BP in the VFHS and UPS (rs13331086 and rs11074553) was conducted using commercially available TaqMan assays on the ABI Prism 7900HT Sequence Detection System (Applied Biosystems) in the SHS. Genotypes of these 2 SNPs in the GRAPHIC Study were retrieved from large-scale genotyping conducted using a 50K Illumina Human CVD BeadChip array. 15 Genotypes for all of the SNPs passed our quality control thresholds (call rate: Ͼ90%) and were in Hardy-Weinberg equilibrium (PϾ0.05).
Statistical Analysis
Means or proportions for BP and covariates were calculated for each population. Genotypes were tested for Mendelian inconsistencies using family based association test software (http://www.hsph. harvard.edu/ϳfbat/fbat.htm). Before statistical analysis, BP values were adjusted for treatment by adding 10 mm Hg to SBP and 5 mm Hg to DBP according to previously described and validated methods. 16, 17 Initial investigation of association with BP phenotypes was performed in the VFHS population using quantitative trait linkage disequilibrium (QTLD) analysis 18 in SOLAR (Sequential Oligogenic Linkage Analysis Routines) 19 using a variance components model specific to the VFHS family structure, including additive genetic, shared environment, and nonshared environmental components of variance (described in detail in the online Data Supplement). To adjust for multiple testing, we used the Single Nucleotide Polymorphism Spectral Decomposition method of correcting for nonindependence of SNPs in linkage disequilibrium (LD) with each other. 20 We did not correct for the number of phenotypes tested because of the strong linear correlation between SBP and DBP (rϭ0.74).
Associations between SCNN1G SNPs and SBP and DBP in the UPS, GRAPHIC, and SHS were examined using generalized estimating equation analyses with an exchangeable correlation structure to adjust for intrafamilial correlations and using age, sex, and body mass index as additional covariates. In addition, because of the age structure in the GRAPHIC Study (paternal generation: 40 -60 years; offspring: 18 -40 years), we included age 2 as an additional covariate in the association analysis. In the UPS (with 3 generations) we included age. 3 We then combined the inverse variance-weighted averages of ␤-coefficients and SEs from VFHS, UPS, GRAPHIC, and SCS in a fixed-effects meta-analysis. A summary effect size and overall P value were calculated for the combined sample under an additive model of inheritance using METAL software (http://www.sph.umich. edu/csg/abecasis/metal/index.html). The between-study heterogeneity was evaluated using a 2 test.
Genotype Imputation Analyses
To evaluate whether the association signal could be attributed to other SNPs in the region, we performed imputation of genotypes in the GRAPHIC cohort. A total of 11 SCNN1G SNPs genotyped using the 50K Illumina Human CVD BeadChip array in the GRAPHIC cohort 21 and listed in Table S2 were used for imputation. All of these SNPs were in Hardy-Weinberg equilibrium (in the parental generation; PϾ0.05) and had very low missingness rate (Ͻ2%). The genotyped SNPs provide Ϸ90% coverage for common SCNN1G SNPs (minor allele frequency: Ͼ5%). We used IMPUTE version 2 22, 23 (http://mathgen.stats.ox.ac.uk/ impute/impute_v2.html) to impute genotypes for SNPs in the chromosome 16 interval 23 110 000 to 23 320 000 using reference haplotypes from the 1000 Genomes Project and HapMap Phase 3. We then performed generalized estimating equation analysis on the imputed genotypes as described above. Only genotypes with Ն80% probability after imputation were used in the analyses.
SCNN1G mRNA Expression Analysis
In brief, renal tissue was sampled immediately after surgery from the pole of the kidney that was unaffected by cancer and was secured in RNAlater (Ambion, Austin, TX) for additional mRNA analysis. Total RNA was extracted from 43 human renal samples (24 hypertensive and 19 normotensive; 25 men and 18 women) with the use of a commercially available assay (RNeasy, Qiagen) according to the manufacturer's protocol. First-strand cDNA was synthesized with the use of 500 ng of total RNA and random hexamer primers (High Capacity cDNA Reverse Transcription kit, Applied Biosystems) and analyzed by quantitative PCR using Power SYBR Green chemistry and the Eppendorf Realplex system (Eppendorf, Hamburg, Germany). Predesigned QuantiTect primers (Qiagen) were used (QT00063217) and normalized to expression of the cyclophilin control gene. Each assay was performed in triplicate using 20-L reaction mixtures containing 10 L of Power SYBR Green PCR Master Mix (ϫ2; Applied Biosystems) and 200 nmol/L of forward and reverse primers. Amplification was performed according to the following conditions, 1 cycle at 95°C for 10 minutes, 50 cycles at 95°C for 15 seconds, and 60°C for 1 minute. Melting curve analyses were performed to check PCR product specificity. Data, expressed as cycle threshold (Ct), were used to determine dCt values [Ct(SCNN1G) Ϫ Ct(Control)]. The fold difference in SCNN1G expression between hypertensive and normotensive subjects was calculated according to the following formula: fold differenceϭ2
Ϫ difference between dCt of hypertensive and normotensive samples . 24 Genotyping of rs13331086 was completed in the Silesian Renal Tissue Bank using TaqMan assays on the ABI Prism 7900HT sequence detection system (Applied Biosystems). Because of low minor allele frequency, individuals with a minor homozygous genotype were grouped with heterozygous genotype subjects in the data analysis. A 2-tailed t test was used to compare differences in renal expression of SCNN1G between both groups. Additional information on materials and methods is provided in the online Data Supplement (please see http://hyper.ahajournals.org).
Results
Association Analyses
SCNN1G and BP in the VFHS
Of the 2959 participants in the VFHS cohort, DNA was available for 2876 individuals, and this was included in the present study. Six SNPs were genotyped in this cohort, rs13331086, rs11074553, rs4299163, rs5740, rs4281710, and rs4470152. After adjustment for treatment effect and demographic variables in QTLD analysis, we identified an association between SBP and 1 SCNN1G SNP (rs13331086; QTLD Pϭ0.014; Table 1 ). This result passed the significance threshold of PϽ0.017 as determined by the Single Nucleotide Polymorphism Spectral Decomposition method to account for multiple testing. Our estimations showed that each additional minor allele was associated with a 0.81-mm Hg (SE: Ϯ0.46 mm Hg) increase in SBP ( Table 1 ). The direction of the allele effect on DBP was consistent with SBP, but the association was not significant (Pϭ0.58; Table 1 ). SNP rs11074553 showed borderline association with SBP (Pϭ0.08). No other SNPs displayed any evidence of association with these phenotypes (all other P values Ͼ0.1).
Utah Pedigree Study
Evidence of association in the UPS cohort was detected between the SCNN1G SNP rs13331086 and DBP, each additional copy of the minor allele was associated with a 1-mm Hg (Ϯ0.48 mm Hg; Pϭ0.04) increase in DBP (Table  S3 ). The association between SBP and rs13331086 was not observed in this population (Pϭ0.49). Other SNPs were not associated with BP (all other P values Ͼ0.1).
GRAPHIC Study
There was a borderline association between rs13331086 and SBP (␤ϭ1.15; SEϭ0.6; Pϭ0.06) in the GRAPHIC Study. No association was observed with rs11074553 (all P values Ͼ0.1, see Table S4 ).
Silesian Hypertension Study
In the SHS cohort, there was association between rs13331086 and both SBP (␤ϭ4.25; SEϭ1.74; Pϭ0.02) and DBP (␤ϭ2.05; SEϭ1; Pϭ0.04). No association was observed with rs11074553 (PϾ0.1, see Table S5 ).
Meta-Analysis
In the combined inverse variance effects meta-analysis of the data from the 6753 informative subjects from the VFHS, UPS, SHS, and GRAPHIC cohorts, each copy of the minor allele of rs13331086 was associated with 1.01-mm Hg higher SBP (Pϭ0.002) and 0.52-mm Hg higher DBP (Pϭ0.01) after adjustment for age, sex, and body mass index (Table 2) . There was no evidence of heterogeneity in effect sizes across the 4 populations included in the meta-analysis (Pϭ0.19).
Imputation Analyses
A total of 43 SCNN1G SNPs were included in the analysis of clinic SBP and DBP after all of the postimputation quality filters in the GRAPHIC Study. Generalized estimating equation-based analysis was adjusted for treatment effect, as well as age, age 2 , sex, and body mass index, as per the original analyses. None of the imputed SCNN1G SNPs showed association with clinic BP at the nominal level of statistical significance; however, the magnitude of association with SBP for a total of 26 imputed SNPs (linked to rs13331086, LD r 2 Ͼ0.9; Table S6 ) was similar to that with rs13331086. 
Discussion
In these independent family based analyses of the association of BP with genetic variation in SCNN1G, our attention was focused on the SNP rs13331086, which we had detected as the most significant variant in our previous study. 8 In the present study we undertook family based association analyses in the entire VFHS cohort and obtained corroborative evidence for association between rs13331086 and SBP. Metaanalysis in the 4 populations indicated that the minor allele of this SNP (G) was associated with a 1.01-mm Hg increase in SBP and 0.52-mm Hg increase in DBP. In an individual homozygous for the minor allele of the SNP, this equates to a BP on average 2/1 mm Hg higher than those homozygous for the common allele. Although modest in clinical terms, the magnitude of association between BP and rs13331086 corresponds well with expected effect of a single SNP on this complex, polygenic trait. Similar estimates were documented in a recently published genome-wide association study for BP. 25 The SNP rs13331086 is located in an intronic region of SCNN1G that is not evolutionarily conserved and has no obvious functional annotation; however, according to the University of California, Santa Cruz Genome Browser database (http://genome.ucsc.edu/), the SNP rs13331086 lies within a human expressed sequence tag, and it, therefore, has a potential role as a regulator of SCNN1G expression. It is possible that a functional variant in strong LD with rs13331086 could be a driver for the observed association. Indeed, 26 SCNN1G SNPs are in strong LD with rs13331086 ( Figure) . Of these, Ն3 may affect mRNA structure/protein function when introduced into in silico analyses. The SNP rs5723 is a synonymous coding variant, and SNP rs5727 is located in the 3Ј untranslated region and is predicted in silico by the SNP Function Annotation Portal (http://brainarray. mbni.med.umich.edu/Brainarray/default.asp) to be a potential microRNA binding site for hsa-miR-29a and hsa-miR-29c, whereas SNP rs13306653 is predicted to be in a functional region of the gene (splice site). Similar to rs13331086, these 3 potentially functional SNPs showed borderline association with clinic SBP in the imputation analysis.
This predominantly genetic analysis was not designed to investigate potential phenotypic correlates in any detailed fashion. The availability of data from the UPS cohort regarding relevant urinary and plasma measures related to the renal function of the ENaC offered an opportunity for preliminary analysis. We found that the G allele of rs13331086, which is associated with higher BP, was also associated with increased urinary potassium excretion measured over a 12-hour overnight period. One could postulate increased expression of ENaC in the distal nephron of the kidney that would favor increased sodium reabsorption, which, as a result of subsequent electrochemical gradients, would favor the excretion of potassium via the renal outer medullary potassium channel. 26 We did not observe any significant association of the SNP with either urinary Na or the Na/K ratio. A previous study examining hypertensive patients compared with normotensive controls found that variants in the ␤-and ␥-subunit ENaC genes were associated with the urinary potassium/ plasma renin ratio, although they did not detect association with either variable alone. 27 They suggested that, even without strong effects on the phenotypes, the variants could act as subtle genes conferring predisposition to sodium retention and hypertension acting continuously over a lifetime. In addition, a recently published study has shown that SCNN1G variants are associated with the BP response to dietary sodium intake, indicating that SCNN1G may be involved in short-term response to sodium. 28 Accordingly, the expression study of human renal tissue indicates a trend toward increased expression of SCNN1G mRNA in hypertensive patients compared with controls. Although not significant and although it may not be directly linked to the SNP rs13331086, the fact that this trend emerges from the diverse sources of confounding variables that might obscure potentially subtle expression changes in the kidney indicates a potentially important lead that requires more detailed studies. It is clear that an increase in ENaC expression is associated with the development of hypertension, whereas the inverse is related to decreased BP, as is evident in the phenotypes of Liddle syndrome and pseudohypoaldosteronism type I, respectively. 29 Moreover, decreased ENaC expression/activity has been shown to prevent the development of hypertension in a mouse model of activation of the thiazide-sensitive sodium chloride cotransporter. 30 To our knowledge, this is the first study to compare the expression of ENaC between hypertensive and normotensive kidneys in humans.
It would be fair to acknowledge that, although traditionally considered as a renal determinant of BP, the ENaC is also expressed in other tissues. For example, ENaC has been located on smooth muscle cells in arteries where it appears to serve as an initiator of pressure-dependent myogenic responses in juxtamedullary afferent arterioles. 31 Other vascular autoregulatory roles of this channel have been attributed to endothelial mechanisms that mediate the arterial flowdependent vasodilatation. Evidence exists that ENaC mediates sodium entry into endothelial cells, thereby altering their deformability and sensitivity to shear stress that results in the release of NO and, consequently, vasodilatation. 32 These channels are also known to exist in central nervous regions involved in BP homeostasis and have been identified as important mediators of aldosterone production in the adrenal cortex. 33, 34 
Perspectives
Identifying the genes responsible for population variation in BP is a complex challenge. Although the large genome-wide association studies have been successful in identifying novel genes for multiple complex disorders, in the field of hypertension they have had limited success. Using a candidate gene approach with a strong physiological justification, we have identified a common genetic variant in the SCNN1G gene associated with increased SBP and DBP in a meta-analysis of Ͼ6000 individuals. In addition, our preliminary experiments indicate increased SCNN1G mRNA expression in hypertensive patients and hint at increased ENaC activity in subjects carrying the minor allele. This common variant with relatively small phenotypic effects on a population-wide basis adds to the role for SCNN1G in BP, better known for the well-characterized rare SCNN1G mutations associated with hypertensive Mendelian diseases. It is clear that a thorough investigation of the physiological actions associated with the rs13331086 SNP and those in strong LD should be a focus for further research. 
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Expanded Methods
QTLD analysis in the VFHS
The variance components models decomposed the total variance σ 2 into additive genetic (σ Shared environment coefficients γ were assumed to be 1 for monozygotic (MZ) and same-sex dizygotic (DZ) twin pairs (that is γ DZ =γ MZ =1), as per the classical twin model. Where individuals j and k are not twins, γ jk was estimated and assumed to be no greater than one. Correlation between spouses was treated differently. No attempt was made to separate this into genetic and environmental components, and γ sp represents the combined correlation 1 . Environmental correlations for both MZ and DZ twin pairs were set equal to 1, in order to satisfy the assumptions of the classic twin model and to ensure identifiability. SOLAR uses matrix notation which requires the use of Δ (the probability that a pair of individuals share 2 alleles IBD) and Φ to determine relationships as described below for the VFHS families. The model was specified such that if Δ was equal to 0.25, it was a sibling pair or DZ twin, and if φ was equal to 0 the pair were spouses.
Multipoint IBD estimation was performed using the SNP genotypes and these values were used to estimate a linkage component of variance (σ 2 Q ), though as there was only SNP data available these did not produce useful estimates and as such were not used in the final analyses. 
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